| Product Code: ETC8287594 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Psoriasis Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Psoriasis Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Psoriasis Market - Industry Life Cycle |
3.4 Mexico Psoriasis Market - Porter's Five Forces |
3.5 Mexico Psoriasis Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Mexico Psoriasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Mexico Psoriasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Mexico Psoriasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Mexico Psoriasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Psoriasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about psoriasis among the population in Mexico |
4.2.2 Growing prevalence of psoriasis cases in Mexico |
4.2.3 Rising investments in research and development for innovative psoriasis treatments |
4.3 Market Restraints |
4.3.1 Limited access to advanced psoriasis treatments in certain regions of Mexico |
4.3.2 High treatment costs associated with biologic drugs for psoriasis management |
4.3.3 Stringent regulatory requirements for approval of new psoriasis treatments in Mexico |
5 Mexico Psoriasis Market Trends |
6 Mexico Psoriasis Market, By Types |
6.1 Mexico Psoriasis Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Mexico Psoriasis Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Mexico Psoriasis Market Revenues & Volume, By Nail Psoriasis, 2021- 2031F |
6.1.4 Mexico Psoriasis Market Revenues & Volume, By Guttate Psoriasis, 2021- 2031F |
6.1.5 Mexico Psoriasis Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2 Mexico Psoriasis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Mexico Psoriasis Market Revenues & Volume, By Tumour necrosis factor inhibitors, 2021- 2031F |
6.2.3 Mexico Psoriasis Market Revenues & Volume, By Vitamin D analogues, 2021- 2031F |
6.2.4 Mexico Psoriasis Market Revenues & Volume, By Interleukin-inhibitors, 2021- 2031F |
6.3 Mexico Psoriasis Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Mexico Psoriasis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.3.3 Mexico Psoriasis Market Revenues & Volume, By Skin Biopsy, 2021- 2031F |
6.4 Mexico Psoriasis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Mexico Psoriasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Mexico Psoriasis Market Revenues & Volume, By Topical, 2021- 2031F |
6.5 Mexico Psoriasis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mexico Psoriasis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Mexico Psoriasis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Mexico Psoriasis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Mexico Psoriasis Market Import-Export Trade Statistics |
7.1 Mexico Psoriasis Market Export to Major Countries |
7.2 Mexico Psoriasis Market Imports from Major Countries |
8 Mexico Psoriasis Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed psoriasis treatments |
8.2 Number of clinical trials conducted for new psoriasis treatments in Mexico |
8.3 Percentage of dermatologists using biologic therapies for psoriasis management |
9 Mexico Psoriasis Market - Opportunity Assessment |
9.1 Mexico Psoriasis Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Mexico Psoriasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Mexico Psoriasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Mexico Psoriasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Mexico Psoriasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Psoriasis Market - Competitive Landscape |
10.1 Mexico Psoriasis Market Revenue Share, By Companies, 2024 |
10.2 Mexico Psoriasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here